/
/
/

Bacil Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)14.17
Volume (₹)49,671.00
High (₹)14.58
Upper Circuit14.58
Low (₹)14.17
Lower Circuit13.20
Prev Close13.89
52W High (₹)61.80
Price14.58
52W Low (₹)10.65

Share Market Cap & Key Ratios Overview

M.Cap (₹)19.94 Cr
Div. Yield (%)0.00
PE Ratio30.30
Debt to Equity0.01
Price to Book2.28
Book Value18.60
EPS (TTM)0.46
Face Value10.00
ROE (%)3.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
BACPHAR-XNSE
LTP
1W Low
1W High
Market cap (₹)
1904-16.1 (-0.84%)
1901
1964.85
4,63,791Cr
9245-24 (-0.26%)
9051.85
9296
2,45,081Cr
4924.7-110.3 (-2.19%)
4890
5049
1,90,351Cr
1135-52 (-4.38%)
1130.75
1191.45
1,14,833Cr
1389-29 (-2.05%)
1388.50
1426.20
1,14,163Cr
1872.15-63.15 (-3.26%)
1812
1947.90
1,00,660Cr
2135-40 (-1.84%)
2135
2209
98,431Cr
2345-42.4 (-1.78%)
2323.15
2407.40
98,305Cr
1155-22.8 (-1.94%)
1155
1179.90
96,906Cr
1627-23 (-1.39%)
1627
1706.70
95,300Cr
14.58+2.58 (21.50%)
12.25
14.58
20Cr

Key Highlights of Bacil Pharma Ltd Balance Sheet

Bacil Pharma Ltd balance sheet discloses shareholders' funds of ₹13.97Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹13.97Cr, and the reserves and surplus of the company is ₹11.46Cr.

The company has its non-current liabilities with total liabilities of ₹25.55Cr as of 2025-03-31.

The current liabilities are ₹16.89Lakh as of 2025-03-31. At the same time, current assets are ₹2.91Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹21.36Cr and tangible assets of 0, provided in the Bacil Pharma Ltd financial statements.